Next Article in Journal
Potential Therapeutic Benefits of Herbs and Supplements in Patients with NAFLD
Previous Article in Journal
Neuropsychiatric Disorders: Influence of Gut Microbe to Brain Signalling
Article Menu
Issue 3 (September) cover image

Export Article

Diseases 2018, 6(3), 79; doi:10.3390/diseases6030079

Case Report
“Holes” in the Jaw—A Report of Two Cases of Periapical Actinomycosis
1
Department of Medicine, University of Miami Miller School of Medicine, Miami, FL 33136, USA
2
Dianon Labcorp, Tampa, FL 33607, USA
*
Author to whom correspondence should be addressed.
Received: 15 August 2018 / Accepted: 5 September 2018 / Published: 6 September 2018

Abstract

:
Periapical actinomycosis is a relatively rare form of cervicofacial actinomycosis, which typically involves the periapical region with subsequent potential spread to the jaw bones. We hereby present two cases of periapical actinomycosis. Both patients presented with jaw pain and “holes” in their gum and lacked the characteristic clinical features commonly seen in cervicofacial actinomycosis such as jaw mass, draining ulcers, sinuses and fistulae. The first patient was an immunocompetent host with chronic stable medical conditions but with a rather bad dentition requiring multiple recent teeth extractions. The second patient was edentulous, had refractory multiple myeloma, was on low-dose chronic steroids and pomalidomide therapy and therefore relatively immunocompromised. Both cases of actinomycosis were diagnosed by jaw bone histopathology, which showed characteristic sulfur granules and embedded Actinomyces-like organisms. The two patients had excellent clinical response to six months of penicillin therapy without any need for surgical intervention. The cases remind clinicians of including actinomycosis in the differential diagnosis of periapical lesions and illustrates the possibility of achieving cure with non-surgical treatment.
Keywords:
cervicofacial actinomycosis; periapical actinomycosis; osteomyelitis; osteonecrosis; penicillin therapy

1. Introduction

Actinomycosis is often known as the great imitator, due to its mimicry of several clinical conditions. These conditions range from bacterial, fungal, mycobacterial and parasitic infections as well as benign and malignant neoplasms [1]. Periapical actinomycosis, a subtype of cervicofacial actinomycosis, typically presents with persistent and recurrent draining fistula in the periapical region—the area around the apex of the tooth root [2]. The infection therefore has a high likelihood of spreading to the adjacent jaw bones [3]. While cervicofacial involvement is the most common overall presentation of actinomycosis, the periapical subtype is still relatively rare, though increasingly reported [2,4,5].
Cervicofacial actinomycosis typically presents as a mass at the angle of the jaw (lumpy jaw) and is commonly associated with external draining ulcers, sinuses, fistulae, and occasionally sulfur granules. The finding of “holes” or large defects of exposed jaw bone inside the mouth cavity is a relatively uncommon presentation of cervicofacial actinomycosis. We present two cases of periapical actinomycotic osteomyelitis. The first case is an immunocompetent host while the second is an immunocompromised host. Both patients presented with “holes” in their gum and lacked the characteristic clinical features commonly seen in actinomycosis. Both cases were diagnosed by histopathology and had an excellent clinical response to six months of penicillin therapy.

2. Case Presentation

2.1. Case 1

This is a 60-year-old man who presented with gum pain of one-month’s duration. His pain emanated from an area of exposed jaw bone in the left lower posterior gum. Two months earlier, he had noticed a blister in the same area, which became an abscess and was subsequently drained. He also had bad dentition that required several recent visits to his dentist. He had multiple recent teeth extractions and several artificial crowns. In addition, he had 20 pounds of weight loss as well as night sweats for the six months prior to presentation. He had no fever, neck mass or external neck draining ulcers.
His past medical history included type 2 diabetes mellitus, hypertension, hyperlipidemia and chronic obstructive pulmonary disease. He had a history of penicillin allergy (rash). He had been recently prescribed oral clindamycin for one month for his oral lesion with no improvement.
His vital signs were normal. Mouth examination showed exposed bone around the root sites of teeth #18 and 19 (see arrow), with artificial crowns over several teeth in the lower jaw (Figure 1). There were no enlarged cervical lymph nodes and examination of other systems was unremarkable.
Biopsy of the left mandibular bone around the root sites of teeth #18 and 19 was obtained and sent for histopathology, aerobic and anaerobic bacterial, fungal and mycobacterial cultures. Bacterial culture grew alpha hemolytic streptococcus, Eikenella corrodens and Micrococcus spp. Fungal and mycobacterial cultures were negative.
Laboratory blood work including complete blood count, electrolytes and kidney function were completely unremarkable.
Computerized tomography maxillofacial imaging showed a lytic lesion in left ramus of the mandible with loss of bone matrix (Figure 2). Chest radiograph was completely normal. Differential diagnoses considered in addition to actinomycosis included nocardiosis, tuberculosis, osteosarcoma of the mandible and endemic fungal infections.
Histopathological examination of the mandibular bone showed osteonecrosis, sulfur granules and embedded organisms on hematoxylin and eosin (H&E) stain (Figure 3 and Figure 4), which were better characterized on Gomori-Grocott methenamine silver stain (GMS) as multiple branching organisms (Figure 5). The official histopathology report read, “acute and chronic osteomyelitis with Actinomyces-like organisms”. A diagnosis of actinomycosis was made, following which the patient was desensitized and treated with intravenous penicillin G for two weeks, followed by oral penicillin VK for six months. He made a complete recovery at the end of therapy with total resolution of symptoms and closure of the exposed bone.

2.2. Case 2

This describes a 70-year-old woman who presented with left upper jaw pain and mastication difficulties of several weeks’ duration. She had undergone complete dental extraction three months earlier. There were no other significant complaints. Her past medical history was significant for multiple myeloma treated with pomalidomide and 20 mg weekly oral dexamethasone for nine years prior to presentation. She also had history of type 2 diabetes mellitus, hypertension and chronic kidney disease stage 3.
Vital signs were within normal limits. Her physical examination was also unremarkable except for the oral examination, which showed she was completely edentulous. In addition, she had an area of sequestrum with overlying calculus noted in the left maxilla bone corresponding to the extraction sites of teeth #11, 12 and 13. There were no surrounding lymph node enlargements or other significant examination findings.
Routine laboratory blood analysis, including complete blood count and complete metabolic profile, was unremarkable.
The piece of sequestrum was removed leaving a “hole” in the upper jaw and was subsequently sent for histopathology. The tissue sections revealed osteonecrosis, osteolytic changes with acute inflammation. The osteolytic spaces were filled with Actinomyces-like organisms and a few fragments of foreign material consistent with vegetables.
The clinical impression of acute osteomyelitis caused by actinomycosis was made. A possible differential that was also considered was medication-related osteonecrosis of the jaw (MRONJ), since she had been on chronic steroids and pomalidomide therapy for several years. Unfortunately, microbiologic cultures were not sent on the specimen obtained from the upper jaw.
The patient was started on a six-month regimen of penicillin VK 500 mg orally four times daily in addition to oral hygiene measures. At her clinic follow-up one month later, her symptoms had completely resolved, and the oral defect was beginning to close. At the end of her six-month therapy, she had made a complete recovery.

3. Discussion

The presented cases illustrate periapical actinomycotic osteomyelitis involving the jaw bones. Periapical actinomycosis is a distinct form of cervicofacial actinomycosis which may or may not be associated with the classic discharging ulcer/sinus at the angle of the jaw [2,6]. Our first patient could be considered immunocompetent while the second patient was clearly immunocompromised, given her history of refractory multiple myeloma and chronic steroid and pomalidomide use. Despite this distinction, the patients shared some similarities in their clinical presentations. The similarities included jaw or gum pain, teeth problems, jaw or gum tissue defects, absence of external draining sinuses, diagnoses made without definitive cultures, and excellent clinical response to prolonged penicillin therapy.
The cases suggest that unexplained gum or jaw problems, especially in the setting of “holes in the gum”, should raise the possibility of cervicofacial actinomycosis. The typical mass at the angle of the jaw (lumpy jaw), draining sinuses with granules from discharging ulcers, abscess formation, fistulae and fibrous tissue formation are not always present, as typified by our cases. In a similar fashion, Kim et al. reported a presentation of actinomycosis mimicking periodontitis without the other classic features associated with cervicofacial actinomycosis [7].
Actinomyces are best described as fastidious, branching, anaerobic to microaerophilic gram-positive bacteria that typically cause acute, subacute or chronic infection in different organ systems. The infection can cross several tissue planes and mimic several other conditions, including malignancy [8]. By crossing tissue planes, the ensuing tissue destruction can result in devastating outcomes, including massive hemorrhage, secondary infection, increased intracranial pressure and septic emboli [6]. The predisposition to cervicofacial actinomycosis in relationship to poor dentition is not far-fetched given the established knowledge that Actinomyces are normal mouth flora [9]. They are also more prevalent in dental plaques, periodontal pockets, gingival crevices and tonsillar crypts. Poor dentition was potentially present in both of our cases and was likely a factor in causing periapical actinomycosis in both patients. Tooth extraction or significant gingival manipulation can also be associated with actinomycosis since disruption of the oral mucosa potentially exposes deeper gingival and periodontal tissues to the Actinomyces-rich oral flora [9,10]. While the mandible is the most commonly involved structure in cervicofacial actinomycosis, involvement of the maxilla is typically rare, accounting for only 5.7% in one review [11,12]. Nevertheless, the maxilla is more commonly involved than the mandible in periapical actinomycosis [4].
Bacterial culture did not grow Actinomyces in our first patient while culture information was not available for our second case. Notwithstanding, given the very fastidious nature of Actinomyces, pathology is a more reliable way for diagnosis, as typified by our first case. Unreported recent antibiotic use, anaerobic requirements and the presence of other competing pathogens often impede the yield of positive Actinomyces culture [13]. Even when bacterial culture is positive, it is often polymicrobial [14,15]. The anaerobic milieu and synergistic contribution between the other mouth bacteria and Actinomyces has been potentially implicated in the tissue destruction seen in actinomycosis [16].
Medication-related osteonecrosis of the jaw (MRONJ) from chronic steroids and pomalidomide use was a diagnostic consideration for our second case. Non-infectious osteonecrosis has been associated with the use of several chronic medications, including intravenous high potency bisphosphonates, denosumab [17], corticosteroids [18], and combination of corticosteroids with taxanes and denosumab [19]. The possible association between actinomycotic osteomyelitis and MRONJ has been previously described and this could also have played a role in the development of osteomyelitis in our second patient [20,21,22].
The contribution of host factors in the predisposition to actinomycosis has been previously published [23,24]. In addition to the immunocompromised state demonstrated in our second patient, other potential host factors present in both patients include age (20 to 60) and diabetes mellitus. Even though our second patient was only taking 20 mg dexamethasone weekly, the cumulative dose and duration of steroid therapy were likely important in contributing to impaired immunity and subsequent increased infection risk [25,26].
Pomalidomide is a thalidomide analogue with antineoplastic, anti-angiogenetic and immunomodulatory properties [27]. Like thalidomide, it is also considered teratogenic. It has a role, in combination with low-dose dexamethasone, in the treatment of multiple myeloma [28,29]. There is evidence to suggest that prolonged therapy with pomalidomide may impair immunity [30].
Our second patient was edentulous. While edentulism is theoretically expected to be associated with less oral infection risk, the negative impact on oral and general health is enormous [31]. The role of complete edentulism as a possible risk factor for actinomycosis has not been well studied, even though limited association has been suggested for mycoplasma and a few other infections [32,33]. Further studies to explore such possible association is recommended.
Both our patients had osteomyelitis in association with actinomycosis and received prolonged therapy for six months with penicillin, which is considered the drug of choice [11,34]. There are, however, other potential treatment options for actinomycosis, including clindamycin, erythromycin, tetracyclines, lincomycin, vancomycin and chloramphenicol [35,36]. Success with shorter treatment options have also been described but will often require surgical debridement [11,37]. Fluoroquinolones, metronidazole and aminoglycosides are considered poor choices, but there is generally good clinical experience with tetracycline and doxycycline even though some regard them as less preferred options [34]. Additionally, some isolates, including Actinomyces europaeus and Actinomyces graevenitzii, are generally resistant to cephalosporins [23,37]. Since almost all isolates are penicillin-sensitive, susceptibility results are seldom pursued. Even though there are several species of Actinomyces, about 70% of all cervical actinomycosis are caused by A. israelii and A. gerencseriae [37]. Finally, when significant tissue necrosis is present, surgical debridement of necrotic tissue is often required for a successful outcome, in addition to appropriate antibiotic therapy [23,38]. Neither of our cases required surgical debridement.
In summary, jaw pain associated with “holes” in the gum or longstanding gum tissue defects should raise suspicion for periapical actinomycosis in the right clinical setting. Making the correct diagnosis may prevent unnecessary work-up and treatment for malignancy which is often a common misdiagnosis in this scenario. The characteristic draining sinus, chronic skin ulcers and fistulae are not always present. Histopathology is often the mainstay of diagnosis and prolonged penicillin therapy for at least six months is the preferred therapy. Surgical debridement is not always necessary as typified by our cases.

Author Contributions

Conceptualization: F.A.; writing—original draft preparation: F.A.; pathology photo slides: A.L.; writing—review and editing: F.A., A.O., A.L.; supervision: None.

Funding

This project received no external funding.

Acknowledgments

Special thanks to Valerie Gramling, University of Miami, Miami, Florida who contributed to the manuscript proofreading and final editing. APC was sponsored by MDPI.

Conflicts of Interest

The authors declare no conflict of interest.

Consent

An informed consent was signed by the patients, giving full permission to publish this manuscript.

References

  1. Grzywa-Celińska, A.; Emeryk-Maksymiuk, J.; Szmygin-Milanowska, K.; Czekajska-Chehab, E.; Milanowski, J. Pulmonary actinomycosis—The great imitator. Ann. Agric. Environ. Med. 2017, 25, 211–212. [Google Scholar] [CrossRef] [PubMed]
  2. Pasupathy, S.P.; Chakravarthy, D.; Chanmougananda, S.; Nair, P.P. Periapical actinomycosis. BMJ Case Rep. 2012. [Google Scholar] [CrossRef] [PubMed]
  3. Ricucci, D.; Siqueira, J.F., Jr. Apical actinomycosis as a continuum of intraradicular and extraradicular infection: Case report and critical review on its involvement with treatment failure. J. Endod. 2008, 34, 1124–1129. [Google Scholar] [CrossRef] [PubMed]
  4. Hirshberg, A.; Tsesis, I.; Metzger, Z.; Kaplan, I. Periapical actinomycosis: A clinicopathologic study. Oral Surg. Oral Med. Oral Pathol. Oral Radiol. Endod. 2003, 95, 614–620. [Google Scholar] [CrossRef] [PubMed]
  5. Esteves, L.S.; Henriques, Á.C.; Silva, C.Á.; Cangussu, M.C.; Ramos, E.A.; Estrela, C.; Santos, J.N. Actinomycosis is not Frequent in the Periapex But is a Persistent Lesion. Braz. Dent. J. 2017, 28, 688–693. [Google Scholar] [CrossRef] [PubMed]
  6. Endo, S.; Mishima, E.; Takeuchi, Y.; Ohi, T.; Ishida, M.; Yanai, M.; Kiyomoto, H.; Nagasawa, T.; Ito, S. Periodontitis-associated septic pulmonary embolism caused by Actinomyces species identified by anaerobic culture of bronchoalveolar lavage fluid: A case report. BMC Infect. Dis. 2015, 15, 552. [Google Scholar] [CrossRef] [PubMed]
  7. Kim, N.R.; Park, J.B.; Ko, Y. Differential diagnosis and treatment of periodontitis-mimicking actinomycosis. J. Periodontal Implant Sci. 2012, 42, 256–260. [Google Scholar] [CrossRef] [PubMed]
  8. Lerner, P.I. The lumpy jaw. Cervicofacial actinomycosis. Infect. Dis. Clin. N. Am. 1988, 2, 203–220. [Google Scholar]
  9. Cole, M.F.; Bryan, S.; Evans, M.K.; Pearce, C.L.; Sheridan, M.J.; Sura, P.A.; Wientzen, R.; Bowden, G.H. Humoral Immunity to Commensal Oral Bacteria in Human Infants: Salivary Antibodies Reactive with Actinomyces naeslundii Genospecies 1 and 2 during Colonization. Infect. Immun. 1998, 66, 4283–4289. [Google Scholar] [PubMed]
  10. Cho, J.Y. The treatment of actinomycosis mimicking a retained root tip: A confusing case. J. Korean Assoc. Oral Maxillofac. Surg. 2016, 42, 205–208. [Google Scholar] [CrossRef] [PubMed]
  11. Gannepalli, A.; Ayinampudi, B.K.; Baghirath, P.V.; Reddy, G.V. Actinomycotic Osteomyelitis of Maxilla Presenting as Oroantral Fistula: A Rare Case Report. Case Rep. Dent. 2015, 2015, 689240. [Google Scholar] [CrossRef] [PubMed]
  12. Miller, M.; Haddad, A.J. Cervicofacial actinomycosis. Oral Surg. Oral Med. Oral Pathol. Oral Radiol. Endod. 1998, 85, 496–508. [Google Scholar] [CrossRef]
  13. Rush, J.R.; Sulte, H.R.; Cohen, D.M.; Makkawy, H. Course of infection and case outcome in individuals diagnosed with microbial colonies morphologically consistent with Actinomyces species. J. Endod. 2002, 28, 613–618. [Google Scholar] [CrossRef] [PubMed]
  14. Marx, R.E.; Carlson, E.R.; Smith, B.R.; Toraya, N. Isolation of Actinomyces species and Eikenella corrodens from patients with chronic diffuse sclerosing osteomyelitis. J. Oral Maxillofac. Surg. 1994, 52, 26–33; discussion 33–34. [Google Scholar] [CrossRef]
  15. Ledezma-Rasillo, G.; Flores-Reyes, H.; Gonzalez-Amaro, A.M.; Garrocho-Rangel, A.; Ruiz-Rodriguez Mdel, S.; Pozos-Guillen, A.J. Identification of cultivable microorganisms from primary teeth with necrotic pulps. J. Clin. Pediatr. Dent. 2010, 34, 329–333. [Google Scholar] [CrossRef] [PubMed]
  16. Bennhoff, D.F. Actinomycosis: Diagnostic and therapeutic considerations and a review of 32 cases. Laryngoscope 1984, 94, 1198–1217. [Google Scholar] [CrossRef] [PubMed]
  17. Kitajima, S.; Mizuno, S.; Kogiso, R.; Tsuji, C. Severe Maxillary Medication-related Osteonecrosis of the Jaw. Intern. Med. 2018. [Google Scholar] [CrossRef] [PubMed]
  18. Shigemura, T.; Nakamura, J.; Kishida, S.; Harada, Y.; Ohtori, S.; Kamikawa, K.; Ochiai, N.; Takahashi, K. Incidence of osteonecrosis associated with corticosteroid therapy among different underlying diseases: Prospective MRI study. Rheumatology 2011, 50, 2023–2028. [Google Scholar] [CrossRef] [PubMed]
  19. Oteri, G.; Campisi, G.; Panzarella, V.; Morreale, I.; Nucera, R.; Di Fede, O.; Picone, A.; Marcianò, A. Could the Combined Administration of Bone Antiresorptive Drug, Taxanes, and Corticosteroids Worsen Medication Related Osteonecrosis of the Jaws in Cancer Patients? BioMed Res. Int. 2018, 2018, 4021952. [Google Scholar] [CrossRef] [PubMed]
  20. De Ceulaer, J.; Tacconelli, E.; Vandecasteele, S.J. Actinomyces osteomyelitis in bisphosphonate-related osteonecrosis of the jaw (BRONJ): The missing link? Eur. J. Clin. Microbiol. Infect. Dis. 2014, 33, 1873–1880. [Google Scholar] [CrossRef] [PubMed]
  21. Lee, C.Y.; Pien, F.D.; Suzuki, J.B. Identification and treatment of bisphosphonate-associated actinomycotic osteonecrosis of the jaws. Implant Dent. 2011, 20, 331–336. [Google Scholar] [CrossRef] [PubMed]
  22. Anavi-Lev, K.; Anavi, Y.; Chaushu, G.; Alon, D.M.; Gal, G.; Kaplan, I. Bisphosphonate related osteonecrosis of the jaws: Clinico-pathological investigation and histomorphometric analysis. Oral Surg. Oral Med. Oral Pathol. Oral Radiol. 2013, 115, 660–666. [Google Scholar] [CrossRef] [PubMed]
  23. Wong, V.K.; Turmezei, T.D.; Weston, V.C. Actinomycosis. BMJ 2011, 343, d6099. [Google Scholar] [CrossRef] [PubMed]
  24. Lisa-Gracia, M.; Martín-Rivas, B.; Pajarón-Guerrero, M.; Arnáiz-García, A. Abdominal actinomycosis in the last 10 years and risk factors for appendiceal actinomycosis: Review of the literature. Turk. J. Med. Sci. 2017, 47, 98–102. [Google Scholar] [CrossRef] [PubMed]
  25. Dixon, W.G.; Abrahamowicz, M.; Beauchamp, M.E.; Ray, D.W.; Bernatsky, S.; Suissa, S.; Sylvestre, M.P. Immediate and delayed impact of oral glucocorticoid therapy on risk of serious infection in older patients with rheumatoid arthritis: A nested case-control analysis. Ann. Rheum. Dis. 2012, 71, 1128–1133. [Google Scholar] [CrossRef] [PubMed]
  26. Fuenfer, M.M.; Olson, G.E.; Polk, H.C., Jr. Effect of various corticosteroids upon the phagocytic bactericidal activity of neutrophils. Surgery 1975, 78, 27–33. [Google Scholar] [PubMed]
  27. Li, Y.; Liu, L.; Wang, X.; Zhang, C.; Reyes, J.; Hoffmann, M.; Palmisano, M.; Zhou, S. In Vivo Assessment of the Effect of CYP1A2 Inhibition and Induction on Pomalidomide Pharmacokinetics in Healthy Subjects. J. Clin. Pharmacol. 2018, 58, 1295–1304. [Google Scholar] [CrossRef] [PubMed]
  28. Lacy, M.Q.; Hayman, S.R.; Gertz, M.A.; Short, K.D.; Dispenzieri, A.; Kumar, S.; Greipp, P.R.; Lust, J.A.; Russell, S.J.; Dingli, D.; et al. Pomalidomide (CC4047) plus low dose dexamethasone (Pom/dex) is active and well tolerated in lenalidomide refractory multiple myeloma (MM). Leukemia 2010, 24, 1934–1939. [Google Scholar] [CrossRef] [PubMed]
  29. Leleu, X.; Attal, M.; Arnulf, B.; Moreau, P.; Traulle, C.; Marit, G.; Mathiot, C.; Petillon, M.O.; Macro, M.; Roussel, M.; et al. Pomalidomide plus low-dose dexamethasone is active and well tolerated in bortezomib and lenalidomide-refractory multiple myeloma: Intergroupe Francophone du Myélome 2009-02. Blood 2013, 121, 1968–1975. [Google Scholar] [CrossRef] [PubMed]
  30. Galustian, C.; Meyer, B.; Labarthe, M.C.; Dredge, K.; Klaschka, D.; Henry, J.; Todryk, S.; Chen, R.; Muller, G.; Stirling, D.; et al. The anti-cancer agents lenalidomide and pomalidomide inhibit the proliferation and function of T regulatory cells. Cancer Immunol. Immunother. 2009, 58, 1033–1045. [Google Scholar] [CrossRef] [PubMed]
  31. Emami, E.; de Souza, R.F.; Kabawat, M.; Feine, J.S. The impact of edentulism on oral and general health. Int. J. Dent. 2013, 2013, 498305. [Google Scholar] [CrossRef] [PubMed]
  32. Gordon, A.M.; Dick, H.M.; Mason, D.K.; Manderson, W.; Crichton, W.B. Mycoplasmas and recurrent oral ulceration. J. Clin. Pathol. 1967, 20, 865–869. [Google Scholar] [CrossRef] [PubMed]
  33. Taboza, Z.A.; Costa, K.L.; Silveira, V.R.; Furlaneto, F.A.; Montenegro, R., Jr.; Russell, S.; Dasanayake, A.; Rego, R.O. Periodontitis, edentulism and glycemic control in patients with type 2 diabetes: A cross-sectional study. BMJ Open Diabetes Res. Care 2018, 6, e000453. [Google Scholar] [CrossRef] [PubMed]
  34. Smith, A.J.; Hall, V.; Thakker, B.; Gemmell, C.G. Antimicrobial susceptibility testing of Actinomyces species with 12 antimicrobial agents. J. Antimicrob. Chemother. 2005, 56, 407–409. [Google Scholar] [CrossRef] [PubMed]
  35. Crossman, T.; Herold, J. Actinomycosis of the maxilla—A case report of a rare oral infection presenting in general dental practice. Br. Dent. J. 2009, 206, 201–202. [Google Scholar] [CrossRef] [PubMed]
  36. Alamillos-Granados, F.J.; Dean-Ferrer, A.; García-López, A.; López-Rubio, F. Actinomycotic ulcer of the oral mucosa: An unusual presentation of oral actinomycosis. Br. J. Oral Maxillofac. Surg. 2000, 38, 121–123. [Google Scholar] [CrossRef] [PubMed]
  37. Valour, F.; Sénéchal, A.; Dupieux, C.; Karsenty, J.; Lustig, S.; Breton, P.; Gleizal, A.; Boussel, L.; Laurent, F.; Braun, E.; Chidiac, C. Actinomycosis: Etiology, clinical features, diagnosis, treatment, and management. Infect. Drug Resist. 2014, 7, 183–197. [Google Scholar] [PubMed]
  38. Sezer, B.; Akdeniz, B.G.; Günbay, S.; Hilmioğlu-Polat, S.; Başdemir, G. Actinomycosis osteomyelitis of the jaws: Report of four cases and a review of the literature. J. Dent. Sci. 2017, 12, 301–307. [Google Scholar] [CrossRef]
Figure 1. Photograph of the open mouth with arrow pointed at exposed bone around teeth #18 and 19.
Figure 1. Photograph of the open mouth with arrow pointed at exposed bone around teeth #18 and 19.
Diseases 06 00079 g001
Figure 2. Maxillofacial computerized tomography imaging showing a lytic lesion in left ramus of the mandible with loss of bone matrix (see arrow).
Figure 2. Maxillofacial computerized tomography imaging showing a lytic lesion in left ramus of the mandible with loss of bone matrix (see arrow).
Diseases 06 00079 g002
Figure 3. Osteonecrosis of the jaw on hematoxylin and eosin stain. Original magnification ×40.
Figure 3. Osteonecrosis of the jaw on hematoxylin and eosin stain. Original magnification ×40.
Diseases 06 00079 g003
Figure 4. Sulfur granule (arrow) showing embedded organisms on H&E stain. Original magnification ×200.
Figure 4. Sulfur granule (arrow) showing embedded organisms on H&E stain. Original magnification ×200.
Diseases 06 00079 g004
Figure 5. Gomori-Grocott methenamine silver stain (GMS) showing multiple branching organisms (arrows). Original magnification ×400.
Figure 5. Gomori-Grocott methenamine silver stain (GMS) showing multiple branching organisms (arrows). Original magnification ×400.
Diseases 06 00079 g005

© 2018 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/).
Diseases EISSN 2079-9721 Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert
Back to Top